- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class A61K 38/04
Total number of patents in this class: 2032
10-year publication summary
|
134
|
134
|
121
|
138
|
98
|
102
|
77
|
79
|
61
|
27
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20902 |
33 |
| Immatics Biotechnologies GmbH | 1126 |
27 |
| Biolinerx Ltd. | 75 |
18 |
| Protagonist Therapeutics, Inc. | 154 |
17 |
| Yale University | 2569 |
15 |
| Biokine Therapeutics Ltd. | 59 |
14 |
| Ramot at Tel-Aviv University Ltd. | 1556 |
14 |
| The Johns Hopkins University | 5938 |
13 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2316 |
13 |
| Mondobiotech Laboratories AG | 310 |
13 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3345 |
13 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1359 |
13 |
| Northwestern University | 3570 |
12 |
| Apellis Pharmaceuticals, Inc. | 135 |
12 |
| Children's Medical Center Corporation | 1969 |
12 |
| The Regents of the University of Michigan | 5038 |
11 |
| Ipsen Pharma S.A.S. | 376 |
11 |
| Centre National de La Recherche Scientifique | 11111 |
10 |
| Agency for Science, Technology and Research | 3765 |
10 |
| The Board of Trustees of the Leland Stanford Junior University | 6711 |
9 |
| Other owners | 1742 |